At present, there are several predictive biomarkers for breast cancer, for example, triple-negative breast cancers (TNBC) which lack estrogen receptor (ER-), progesterone receptor (PR-), and amplification of human epidermal growth factor receptor 2 (HER2-). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.